Sailner Digital Medical
Clinical 3D printing and digital modeling services for cardiovascular, oncology, and bone surgery using proprietary full-color multi-material WJP technology, enabling surgeons to visualize complex anatomical structures for surgical planning and patient-specific medical devices.
- CEO / Founder
- Junzhong Wu (吴俊中)
- Team Size
- 1001-5000
- Stage
- Active
- Total Funding
- $15.66M
- Latest Round
- Pre-Series A
- Key Investors
- Legend Capital
Technology & Products
Key Products
Patient-specific 3D surgical models (cardiovascular, oncology, orthopedic, trauma); Medical 3D printing technical services (custom manufacturing); Surgical planning and guidance systems; Personalized surgical guides and templates; Custom medical implants and prosthetics; Rehabilitation aids and orthotic devices; Anatomical teaching models; Surgical simulation training models; 3D digital reconstruction and modeling software
Technological Advantage
WJP technology proprietary voxel-level control; ability to integrate hard and soft materials in full color enabling anatomically accurate visualization; 40-60% reduction in surgical planning time; cost-per-model approximately 30-50% lower than alternatives due to material efficiency; regulatory pathway clarity with established Class II certification framework.
Differentiation
Value Proposition
Reduces surgical planning time and complexity by 40-60% through patient-specific 3D models; improves surgical precision and reduces operative time; enables personalized implant design; first company in China to obtain 5 Class II medical device registrations for surgical models (cardiovascular, liver, kidney, cranial, lung).
How They Differentiate
Sailner Digital Medical differentiates on: (1) Full-color multi-material capability showing hard+soft tissue in single model vs. monochrome competitors; (2) Faster turnaround time (3-5 days vs. 7-14 days for traditional approaches); (3) Regulatory certification pathway in China (Class II registrations); (4) Cost efficiency through WJP material optimization; (5) Cloud-based surgical planning integration.
Market & Competition
Target Customers
Tertiary hospitals, medical institutions; surgeons and surgical planning teams in cardiovascular, oncology, orthopedic, and trauma fields
Industry Verticals
Medical/Healthcare; Surgical planning; Medical device manufacturing; Orthopedic applications; Cardiovascular applications; Oncology applications
Competitors
RAYSHAPE (dental-focused, material jetting); Sinterit (laser sintering focus); Formlabs (SLA/SLS technology, international leader, strong medical presence)
Growth & Milestones
Growth Metrics
Regulatory milestone: Obtained 5 Class II medical device registration certificates (only Chinese company to achieve this across 5 surgical model types: cardiovascular, liver, kidney, cranial, lung); expanding hospital partnerships across major Chinese medical institutions; scaling production capacity for medical 3D printing services.
Major Milestones
2021: Completed RMB100M+ Pre-A funding round led by Legend Capital; Obtained 5 Class II medical device registration certificates (first in China for surgical models); Established cloud-based surgical planning platform; Integration of MR/AR virtual reality systems for surgical simulation; Expanded product portfolio to include rehabilitation aids and anatomical education models
Notable Customers
Guangdong Provincial People's Hospital (广东省人民医院); Zhuhai Maternal and Child Health Hospital (珠海妇幼保健院); Zhuhai People's Hospital (珠海市人民医院); Sun Yat-sen University Fifth Affiliated Hospital (中山大学附属第五医院); Southern Medical University Third Affiliated Hospital (南方医科大学第三附属医院); Southern Medical University Fifth Affiliated Hospital (南方医科大学第五附属医院)